ACCURAY INC (ARAY)

US0043971052 - Common Stock

2.43  +0.06 (+2.53%)

After market: 2.48 +0.05 (+2.06%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ACCURAY INC

NASDAQ:ARAY (3/27/2024, 8:00:08 PM)

After market: 2.48 +0.05 (+2.06%)

2.43

+0.06 (+2.53%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap240.98M
Shares
PEN/A
Fwd PE17.87
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ARAY Daily chart

Company Profile

Accuray, Inc. is a radiation oncology company. The company is headquartered in Madison, Wisconsin and currently employs 1,024 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Company Info

ACCURAY INC

1240 Deming Way

Madison WISCONSIN 94089

P: 16088242800

CEO: Joshua H. Levine

Employees: 1024

Website: https://www.accuray.com/

ARAY News

News Image2 days ago - Accuray IncorporatedNew Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois...

News Image21 days ago - Market News VideoNotable Thursday Option Activity: AA, ARAY, ABR
News Imagea month ago - Accuray IncorporatedAccuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference...

News Imagea month ago - Market News VideoCommit To Buy Accuray At $2, Earn 8.7% Annualized Using Options
News Imagea month ago - InvestorPlace7 Screaming Stock Buys for Under $5

While these under $5 stocks may be low priced, there’s nothing fundamentally cheap about these compelling enterprises.

News Imagea month ago - Seeking AlphaRoth MKM starts Accuray at buy, cites expansion into emerging markets (NASDAQ:ARAY)

Roth MKM initiated coverage of Accuray (ARAY) with a buy rating, citing the company’s expansion into emerging markets such as China and India. Read more here.

ARAY Twits

Here you can normally see the latest stock twits on ARAY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example